These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30449824)

  • 1. L-Type Amino Acid Transporter 1 Immunoreactivity as a Possible Diagnostic and Prognostic Marker of Thymic Carcinoma.
    Maeda S; Nakazato Y; Hayashi K; Nishihira M; Inoue T; Araki O; Karube Y; Kobayashi S; Chida M
    Tohoku J Exp Med; 2018 Nov; 246(3):167-174. PubMed ID: 30449824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.
    Hayashi K; Jutabha P; Maeda S; Supak Y; Ouchi M; Endou H; Fujita T; Chida M; Anzai N
    J Pharmacol Sci; 2016 Nov; 132(3):201-204. PubMed ID: 27567475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
    Kobayashi H; Ishii Y; Takayama T
    J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
    Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
    Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
    J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma.
    Sato K; Miyamoto M; Takano M; Furuya K; Tsuda H
    Virchows Arch; 2019 Jun; 474(6):701-710. PubMed ID: 30637450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
    Nonaka D; Henley JD; Chiriboga L; Yee H
    Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
    Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
    Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Ogawa H; Kaira K; Motegi Y; Yokobori T; Takada T; Katoh R; Osone K; Takahashi R; Katayama C; Oyama T; Kanai Y; Yao T; Asao T; Kuwano H; Shirabe K
    Anticancer Res; 2019 May; 39(5):2535-2543. PubMed ID: 31092450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
    Kaira K; Sunose Y; Ohshima Y; Ishioka NS; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Yamaguchi A; Segawa A; Ide M; Mori M; Oyama T; Takeyoshi I
    BMC Cancer; 2013 Oct; 13():482. PubMed ID: 24131658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus.
    Sato K; Miyamoto M; Takano M; Tsuda H
    Virchows Arch; 2020 Sep; 477(3):421-427. PubMed ID: 32144539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
    Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of L-type amino acid transporter 1 in epidermal ovarian cancer.
    Kaji M; Kabir-Salmani M; Anzai N; Jin CJ; Akimoto Y; Horita A; Sakamoto A; Kanai Y; Sakurai H; Iwashita M
    Int J Gynecol Cancer; 2010 Apr; 20(3):329-36. PubMed ID: 20375792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma.
    Shimizu A; Kaira K; Okubo Y; Utsumi D; Yasuda M; Tominaga H; Oriuchi N; Kanai Y; Takahashi K; Ishikawa O
    Neoplasma; 2017; 64(2):283-288. PubMed ID: 28052681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type amino acid transporter 1 expression in esophageal carcinogenesis according to WHO and Japanese classifications of intraepithelial neoplasia.
    Hashimoto H; Kurata A; Kikuchi H; Masuda Y; Fujita K; Okuyama R; Inoue S; Horiuchi H; Kuroda M
    Pathol Int; 2017 May; 67(5):247-255. PubMed ID: 28370814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.